Please login to the form below
disease management
This page shows the latest disease management news and features for those working in and with pharma, biotech and healthcare.
Facts are stubborn things
In the fast-moving world of science, where there is rarely universal consensus on disease management and treatment, where inter-patient disease heterogeneity is a given and where the art or
Latest news
-
How and when should we innovate our strategies to deliver competitive change?
They have the fastest onset, a cleaner safety profile, or a more efficacious impact on disease x. ... our positioning into the fabric of disease management.
-
AstraZeneca and C4X Discovery sign exclusive $403m licensing deal
C4XD's NRF2 Activator programme, with a focus on chronic obstructive pulmonary disease (COPD). ... However, despite COPD being a progressive disease, it is treatable. With proper management, most patients with COPD can achieve good symptom control and
-
Takeda’s Exkivity receives NICE recommendation for rare form of lung cancer
This positive recommendation is fantastic news for patients. Particularly as they have previously faced frustration and isolation due to the limited treatment options available for this aggressive disease,” said Angela Terry, ... She continued:
-
Act-Accelerator outlines plans for longterm COVID-19 control
the public and other partners, in order to aid the transition for long-term COVID-19 management. ... a critical public health threat to the integration of long-term disease management campaigns.
-
The health paradigm shift
Firstly, should we be restricting ourselves to ‘treatment’ paradigm change? Are we not actually striving for complete disease management change? ... If we continue with our working example of bringing in more effective medicines earlier in the
More from news
Approximately 4 fully matching, plus 189 partially matching documents found.
Latest Intelligence
-
Rare diseases: not so rare after all
The development of rare disease management, driven by patient and carer groups and providing motivation for academic researchers, industry, regulatory authorities and healthcare professionals (HCPs) to deliver novel treatments. ... The future. Rare
-
Digital technology: a significant change in healthcare innovation
Advanced, fit-for purpose platforms, mobile applications and devices continue to revolutionise both individual access to healthcare and chronic disease management. ... For clinical trials, companies and investigators are developing digital endpoints to
-
Looking to the future of patient empowerment
PSPs generally encompass:. Training about effective administration of medicines. Helping people understand their condition and advice on disease management. ... Training about effective administration of medicines. Helping people understand their
-
Patient support programmes: providing meaningful care when you dare to treat rare
But when it comes to rare diseases where, for example, in the UK, one disease may only affect 30, 000 people, how do you build a PSP that will have a ... These can be incredibly relevant in rare diseases where new research or opinions can change the
-
Building a brighter future with patient support programmes
They are the multipurpose building blocks that improve patient safety, pharmacovigilance, trial enrolment and retention, disease management, adherence, market share and quality of life for patients. ... HCPs, through longitudinal tracking visualisations
More from intelligence
Approximately 0 fully matching, plus 68 partially matching documents found.
Latest appointments
-
BMS appoints new commercial leader, Davies joins Eisai and more
The field of genomic medicine has the potential to revolutionise our approach to rare genetic disease diagnosis and management, as well as in other areas of personalised medicine.”. ... Atkins said: “Britten joins our Senior Management team at a
-
Hugh Cole joins Jounce Therapeutics as chief business officer
Cole brings over 25 years’ experience in biotech including business development, corporate strategy, R&D, alliance management, commercial planning and execution and corporate leadership. ... He has also held roles for Oscient Pharmaceuticals, The
-
Glyconics appoints CEO
Dr Kam Pooni joins the UK diagnostics firm. UK disease management diagnostics firm Glyconics has appointed Dr Kam Pooni as chief executive officer with immediate effect.
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
The ever-shifting landscape of health wearables
A whole host of health and fitness apps have now been developed to work in conjunction with wearable tech – running apps, mindfulness apps, ECG apps, blood pressure apps, nutrition apps, disease ... One particular area in which there are high hopes for
-
Pharmacogenomics supports and new era of precision medicine
Research shows that 99% of people carry at least one genetic variation that can affect their response to certain drugs including commonly prescribed painkillers, heart disease treatments, and antidepressants. ... While there is still quite a distance to
-
Diabetes management – should there be a 'one-size fit all' approach?
For Diabetes Awareness Week 2022, we discussed diabetes as a chronic condition, and the increasing importance of home-based disease management. ... To combat this, the NHS long-term plan set out ambitions to invest more heavily in support for home-based
-
Report: Omnichannel advice for the life science industry
Moreover, the emergence of new disease‑monitoring technologies has empowered them to take a more active role in developing their disease management plan.
-
Virtualizing Healthcare with Human-Centric Technology
Dr. Patrick Carroll, Chief Medical Officer at Vida Health, discusses the importance of using a “whole health” approach to chronic disease management, how and why the human connection with a provider
More from PMHub
Approximately 0 fully matching, plus 46 partially matching documents found.
Subscribe to our email news alerts
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- AbbVie’s Rinvoq receives FDA approval for Crohn’s disease
- Bayer’s Nubeqa combination recommended by NICE to treat metastatic prostate cancer
- AstraZeneca announces positive phase 3 results for Tagrisso combination in lung cancer
- Bristol Myers Squibb presents positive results for idiopathic pulmonary fibrosis drug
- FDA approves Blueprint Medicines’ Ayvakit for indolent systemic mastocytosis
- Novo Nordisk announces positive phase 3 results for oral weight-loss drug
- Medscape Medical Affairs Selected as Finalist for 2023 Communiqué Awards
- COVID-19: Pfizer’s Paxlovid approved by FDA and Gilead’s Veklury recommended by CHMP
- BMS and Janssen’s antithrombotic granted FDA fast track designation
- Gene therapy, gene editing and perspectives on future use in Parkinson’s disease
- Patient Clinical Trial & Communications Plan Review: A Customer Story
- Shining a Spotlight on Women’s Health Education Outcomes at ACOG 2023
PMHub
Innovative Trials
Innovative Trials is a leading global clinical trial patient recruitment company. With over 10 years’ experience, Innovative Trials deploys “boots-on-the-ground”...
Latest intelligence
- Patient Clinical Trial & Communications Plan Review: A Customer Story
- ...
- Working together to achieve better patient pathways
- Digital tools can supercharge patient treatment and outcomes but the importance of the patient voice cannot be underestimated...
- Design-thinking. Iterating for continuous improvement.
- How design can lead improvement within Pharma...
